Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terra Lasho

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Best Practice & Research. Clinical Haematology|May 29, 2020
Atypical CML- the role of morphology and precision genomicsTerra Lasho
Best Practice & Research. Clinical Haematology|March 25, 2021
Novel therapeutic targets for chronic myelomonocytic leukemiaTerra Lasho, Mrinal M Patnaik
Best Practice & Research. Clinical Haematology|May 29, 2020
Juvenile myelomonocytic leukemia - A bona fide RASopathy syndromeTerra Lasho, Mrinal M Patnaik
Hematology. American Society of Hematology. Education Program|December 4, 2020
Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused reviewMrinal M Patnaik, Terra Lasho
Current Hematologic Malignancy Reports|December 14, 2023
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology DisordersTerra Lasho, Mrinal M Patnaik
Blood|May 24, 2006
Discordant distribution of JAK2V617F mutation in siblings with familial myeloproliferative disordersAnimesh Pardanani, Terra Lasho, Rebecca McClure, et al.
American Journal of Hematology|March 29, 2011
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosisAnimesh Pardanani, Kebede Begna, Christy Finke, et al.
Leukemia Research|December 30, 2023
VEXAS syndrome in a patient with DDX41 germline predisposition syndromeYael Kusne, Terra Lasho, Christy Finke, et al.
American Journal of Hematology|December 15, 2015
Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutationAnimesh Pardanani, Terra Lasho, Daniela Barraco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling studyAyalew Tefferi, Rakhee Vaidya, Domenica Caramazza, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Best Practice & Research. Clinical Haematology|May 29, 2020
Atypical CML- the role of morphology and precision genomicsTerra Lasho
Best Practice & Research. Clinical Haematology|March 25, 2021
Novel therapeutic targets for chronic myelomonocytic leukemiaTerra Lasho, Mrinal M Patnaik
Best Practice & Research. Clinical Haematology|May 29, 2020
Juvenile myelomonocytic leukemia - A bona fide RASopathy syndromeTerra Lasho, Mrinal M Patnaik
Hematology. American Society of Hematology. Education Program|December 4, 2020
Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused reviewMrinal M Patnaik, Terra Lasho
Current Hematologic Malignancy Reports|December 14, 2023
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology DisordersTerra Lasho, Mrinal M Patnaik
Blood|May 24, 2006
Discordant distribution of JAK2V617F mutation in siblings with familial myeloproliferative disordersAnimesh Pardanani, Terra Lasho, Rebecca McClure, et al.
American Journal of Hematology|March 29, 2011
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosisAnimesh Pardanani, Kebede Begna, Christy Finke, et al.
Leukemia Research|December 30, 2023
VEXAS syndrome in a patient with DDX41 germline predisposition syndromeYael Kusne, Terra Lasho, Christy Finke, et al.
American Journal of Hematology|December 15, 2015
Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutationAnimesh Pardanani, Terra Lasho, Daniela Barraco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling studyAyalew Tefferi, Rakhee Vaidya, Domenica Caramazza, et al.
Pageof 7